Mitchell Evers

513 total citations
13 papers, 344 citations indexed

About

Mitchell Evers is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology and Molecular Biology. According to data from OpenAlex, Mitchell Evers has authored 13 papers receiving a total of 344 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Radiology, Nuclear Medicine and Imaging, 7 papers in Immunology and 4 papers in Molecular Biology. Recurrent topics in Mitchell Evers's work include Monoclonal and Polyclonal Antibodies Research (9 papers), T-cell and B-cell Immunology (4 papers) and Immune Cell Function and Interaction (4 papers). Mitchell Evers is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (9 papers), T-cell and B-cell Immunology (4 papers) and Immune Cell Function and Interaction (4 papers). Mitchell Evers collaborates with scholars based in Netherlands, Germany and Norway. Mitchell Evers's co-authors include Jeanette H.W. Leusen, Thomas Valerius, J.H. Marco Jansen, Maaike Nederend, Toine ten Broeke, Thies Rösner, Arianne M. Brandsma, Geert van Tetering, Saskia Meyer and Jeannette Nilsen and has published in prestigious journals such as SHILAP Revista de lepidopterología, Frontiers in Immunology and British Journal of Haematology.

In The Last Decade

Mitchell Evers

12 papers receiving 339 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mitchell Evers Netherlands	9	222	152	89	81	33	13	344
Saskia Meyer Netherlands	11	298 1.3×	242 1.6×	99 1.1×	169 2.1×	32 1.0×	16	454
Robert Oldham United Kingdom	10	198 0.9×	223 1.5×	151 1.7×	148 1.8×	66 2.0×	15	423
Laura Cons Switzerland	7	185 0.8×	110 0.7×	79 0.9×	152 1.9×	15 0.5×	12	359
Diane Stone United States	11	104 0.5×	259 1.7×	93 1.0×	73 0.9×	18 0.5×	16	435
S. Goldberg United States	11	288 1.3×	63 0.4×	182 2.0×	124 1.5×	32 1.0×	15	439
Simone Battella Italy	11	271 1.2×	44 0.3×	206 2.3×	62 0.8×	21 0.6×	18	382
Tiffany A. Coupet United States	5	204 0.9×	160 1.1×	323 3.6×	128 1.6×	9 0.3×	7	428
Heather Huet United States	6	105 0.5×	88 0.6×	79 0.9×	133 1.6×	12 0.4×	13	264
Maria Liljefors Sweden	12	243 1.1×	85 0.6×	224 2.5×	133 1.6×	14 0.4×	20	451
Emily Y. Jen United States	7	82 0.4×	51 0.3×	147 1.7×	119 1.5×	22 0.7×	9	320

Countries citing papers authored by Mitchell Evers

Since Specialization

Citations

This map shows the geographic impact of Mitchell Evers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitchell Evers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitchell Evers more than expected).

Fields of papers citing papers by Mitchell Evers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitchell Evers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitchell Evers. The network helps show where Mitchell Evers may publish in the future.

Co-authorship network of co-authors of Mitchell Evers

This figure shows the co-authorship network connecting the top 25 collaborators of Mitchell Evers. A scholar is included among the top collaborators of Mitchell Evers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mitchell Evers. Mitchell Evers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Foss, Stian, J.H. Marco Jansen, Mitchell Evers, et al.. (2025). Engineering of anticancer human immunoglobulin A equipped with albumin for enhanced plasma half-life. PNAS Nexus. 4(2). pgaf042–pgaf042. 3 indexed citations

Evers, Mitchell, I. Quintus Molenaar, Hjalmar C. van Santvoort, et al.. (2025). The Efficacy of Targeted Monoclonal IgA Antibodies Against Pancreatic Ductal Adenocarcinoma. Cells. 14(9). 632–632.

Evers, Mitchell, Maaike Nederend, Karli R. Reiding, et al.. (2023). IgA antibody immunotherapy targeting GD2 is effective in preclinical neuroblastoma models. Journal for ImmunoTherapy of Cancer. 11(7). e006948–e006948. 16 indexed citations

Jansen, J.H. Marco, et al.. (2023). Characterization of human Fc alpha receptor transgenic mice: comparison of CD89 expression and antibody-dependent tumor killing between mouse strains. Cancer Immunology Immunotherapy. 72(9). 3063–3077. 8 indexed citations

Evers, Mitchell, Thies Rösner, J.H. Marco Jansen, et al.. (2021). The selection of variable regions affects effector mechanisms of IgA antibodies against CD20. Blood Advances. 5(19). 3807–3820. 11 indexed citations

Evers, Mitchell, Kaylee M. Keller, Hanneke L.D.M. Willemen, et al.. (2021). Anti-GD2 IgA kills tumors by neutrophils without antibody-associated pain in the preclinical treatment of high-risk neuroblastoma. Journal for ImmunoTherapy of Cancer. 9(10). e003163–e003163. 21 indexed citations

Evers, Mitchell, Saskia Meyer, Jeannette Nilsen, et al.. (2021). Extended plasma half-life of albumin-binding domain fused human IgA upon pH-dependent albumin engagement of human FcRnin vitroandin vivo. mAbs. 13(1). 34 indexed citations

Tetering, Geert van, et al.. (2020). Fc Engineering Strategies to Advance IgA Antibodies as Therapeutic Agents. SHILAP Revista de lepidopterología. 9(4). 70–70. 45 indexed citations

Evers, Mitchell, Toine ten Broeke, J.H. Marco Jansen, et al.. (2020). Novel chimerized IgA CD20 antibodies: Improving neutrophil activation against CD20-positive malignancies. mAbs. 12(1). 1795505–1795505. 17 indexed citations

10.

Brandsma, Arianne M., Mitchell Evers, Maaike Nederend, et al.. (2019). Potent Fc Receptor Signaling by IgA Leads to Superior Killing of Cancer Cells by Neutrophils Compared to IgG. Frontiers in Immunology. 10. 704–704. 109 indexed citations

11.

Rösner, Thies, Hanke L. Matlung, J.H. Marco Jansen, et al.. (2018). Immune Effector Functions of Human IgG2 Antibodies against EGFR. Molecular Cancer Therapeutics. 18(1). 75–88. 25 indexed citations

12.

Evers, Mitchell, Margot Jak, & Jeanette H.W. Leusen. (2018). The latest developments with anti-CD20 monoclonal antibodies in chronic lymphocytic leukemia. Expert Opinion on Biological Therapy. 18(9). 973–982. 7 indexed citations

13.

Meyer, Saskia, Mitchell Evers, J.H. Marco Jansen, et al.. (2018). New insights in Type I and II CD20 antibody mechanisms‐of‐action with a panel of novel CD20 antibodies. British Journal of Haematology. 180(6). 808–820. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact